Mitja Lainscak

Summary

Affiliation: University Medical Centre
Country: Slovenia

Publications

  1. pmc Pharmacokinetics of drugs in cachectic patients: a systematic review
    Katja Trobec
    Pharmacy Department, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    PLoS ONE 8:e79603. 2013
  2. pmc Exercise-induced changes in iron status and hepcidin response in female runners
    Irena Auersperger
    Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia
    PLoS ONE 8:e58090. 2013
  3. doi request reprint Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    J Am Med Dir Assoc 14:450.e1-6. 2013
  4. doi request reprint Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention
    Mitja Lainscak
    Division of Cardiology, University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
    Curr Opin Clin Nutr Metab Care 16:278-83. 2013
  5. doi request reprint Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis
    Mitja Lainscak
    Division of Cardiology, University Clinic Golnik, Golnik, Slovenia
    Int J Cardiol 163:87-92. 2013
  6. ncbi request reprint Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Eur J Heart Fail 9:1095-103. 2007
  7. doi request reprint Atrial fibrillation in chronic non-cardiac disease: where do we stand?
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
    Int J Cardiol 128:311-5. 2008
  8. ncbi request reprint Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Int J Cardiol 122:149-55. 2007
  9. doi request reprint Cachexia: common, deadly, with an urgent need for precise definition and new therapies
    Mitja Lainscak
    Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
    Am J Cardiol 101:8E-10E. 2008
  10. doi request reprint The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    Mitja Lainscak
    University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    Wien Klin Wochenschr 121:309-13. 2009

Detail Information

Publications67

  1. pmc Pharmacokinetics of drugs in cachectic patients: a systematic review
    Katja Trobec
    Pharmacy Department, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    PLoS ONE 8:e79603. 2013
    ..Because no general guidelines exist for drug dose adjustments in cachectic patients, we conducted a systematic search to identify articles that investigated the pharmacokinetics of drugs in cachectic patients. ..
  2. pmc Exercise-induced changes in iron status and hepcidin response in female runners
    Irena Auersperger
    Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia
    PLoS ONE 8:e58090. 2013
    ..Exercise-induced iron deficiency is a common finding in endurance athletes. It has been suggested recently that hepcidin may be an important mediator in this process...
  3. doi request reprint Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    J Am Med Dir Assoc 14:450.e1-6. 2013
    ..To test whether coordination of discharge from hospital reduces hospitalizations in patients with chronic obstructive pulmonary disease (COPD)...
  4. doi request reprint Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention
    Mitja Lainscak
    Division of Cardiology, University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
    Curr Opin Clin Nutr Metab Care 16:278-83. 2013
    ..Hospitalizations due to exacerbation of chronic obstructive pulmonary disease (COPD) are a major burden for patient and healthcare system. Extra-pulmonary needs and resulting interventions are poorly investigated...
  5. doi request reprint Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis
    Mitja Lainscak
    Division of Cardiology, University Clinic Golnik, Golnik, Slovenia
    Int J Cardiol 163:87-92. 2013
    ..We aimed to evaluate the relation between SRH and adverse events during titration of beta-blockers in elderly patients with heart failure...
  6. ncbi request reprint Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Eur J Heart Fail 9:1095-103. 2007
    ..There are limited data on recall and implementation of lifestyle advice in patients with heart failure (HF)...
  7. doi request reprint Atrial fibrillation in chronic non-cardiac disease: where do we stand?
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
    Int J Cardiol 128:311-5. 2008
    ..In this paper, we review data on incidence, prognostic importance and treatment modalities of atrial fibrillation in patients with cancer, chronic obstructive pulmonary disease, and chronic kidney disease...
  8. ncbi request reprint Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Int J Cardiol 122:149-55. 2007
    ..Beta-blockers are well established for treatment of chronic heart failure (CHF). However, the extent of implementation of trial results and guidelines in daily practice remains limited, and information regarding how patients feel is scarce...
  9. doi request reprint Cachexia: common, deadly, with an urgent need for precise definition and new therapies
    Mitja Lainscak
    Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
    Am J Cardiol 101:8E-10E. 2008
    ..Among the recognized approaches, exogenous oral amino acid supplementation appears very promising. Further research efforts are needed and they are ongoing...
  10. doi request reprint The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure
    Mitja Lainscak
    University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    Wien Klin Wochenschr 121:309-13. 2009
    ..Our aim was to determine the prevalence and clinical impact of COPD among patients hospitalized for heart failure in a community hospital serving a population of 125,000 people...
  11. doi request reprint How does cachexia influence survival in cancer, heart failure and other chronic diseases?
    Mitja Lainscak
    Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
    Curr Opin Support Palliat Care 1:299-305. 2007
    ..Ultimately, cachexia may develop in 10-15% of patients, who usually perish soon after. We currently have neither a globally accepted definition of cachexia nor any treatment to prevent or treat cachexia...
  12. doi request reprint Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik 36, SI 4204 Golnik, Slovenia
    Eur J Heart Fail 12:193-6. 2010
    ..The MARVEL-1 trial raises further concerns about the safety of myoblast transplantation in ischaemic HF...
  13. ncbi request reprint Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers
    Mitja Lainscak
    Department of Cardiology, Division of Applied Cachexia Research, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Germany
    Int J Cardiol 132:303-11. 2009
    ..Finally, we speculate about the potential of sharing the biomarkers over a variety of chronic diseases with similar pathophysiology...
  14. doi request reprint Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges
    Mitja Lainscak
    Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin, Berlin, Germany
    Herz 34:589-93. 2009
    ..The authors review some of those biomarkers and speculate on the possible roles of combining two or more of them...
  15. doi request reprint Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
    Herz 34:141-7. 2009
    ..There is limited evidence that the use of prognostic markers to make treatment decisions improves the outcome in CHF. Many studies still need to be done to this end...
  16. ncbi request reprint The management of patients with heart failure in a Slovenian community hospital: what has changed between 1997 and 2000?
    Mitja Lainscak
    Internal Medicine Department, General Hospital, Murska Sobota, Slovenia
    Wien Klin Wochenschr 115:334-9. 2003
    ..There is a scarcity of data on changes in the management of patients hospitalized with heart failure...
  17. ncbi request reprint Biomarkers for chronic heart failure
    Mitja Lainscak
    Division of Applied Cachexia Research, Department of Cardiology, Campus Virchow Clinic, Charite Universitatsmedizin Berlin, Berlin, Germany
    Heart Fail Monit 5:77-82. 2007
    ..Lastly, we anticipate the potential of biomarkers in a variety of chronic diseases with similar pathophysiology...
  18. ncbi request reprint Patient's view of heart failure: from the understanding to the quality of life
    Mitja Lainscak
    Internal Medicine Department, General Hospital Murska Sobota, Dr Vrbnjaka 6, SI 9000, Murska Sobota, Slovenia
    Eur J Cardiovasc Nurs 2:275-81. 2003
    ..Hospitalizations and symptoms of heart failure negatively influence patients' quality of life. In Slovenia there is a scarcity of non-pharmacological management and quality of life data in heart failure patients...
  19. ncbi request reprint Infective endocarditis due to Abiotrophia defectiva: a report of two cases
    Mitja Lainscak
    General Hospital Murska Sobota, Murska Sobota, Slovenia
    J Heart Valve Dis 14:33-6. 2005
    ..Endocarditis due to Abiotrophia sp. is rare and often associated with negative blood cultures. The rates of treatment failure, infection relapse and mortality are higher than in endocarditis caused by other viridans streptococci...
  20. ncbi request reprint Validation of self assessment patient knowledge questionnaire for heart failure patients
    Mitja Lainscak
    General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
    Eur J Cardiovasc Nurs 4:269-72. 2005
    ..Only a limited number of validated tools are available to assess their knowledge. The aim of the study was to test our 10-item Patient knowledge questionnaire...
  21. ncbi request reprint Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinic
    Mitja Lainscak
    General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
    Eur J Heart Fail 8:187-90. 2006
    ..Several studies have shown improvement of prognosis in patients managed in heart failure (HF) clinics. However, the value of the individual management components is not well established...
  22. ncbi request reprint Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study
    Mitja Lainscak
    General Hospital Murska Sobota, Internal Medicine Department, Dr Vrbnjaka 6 SI 9000, Murska Sobota, Slovenia
    Int J Cardiol 106:319-22. 2006
    ..Cachexia is an independent risk factor for mortality in chronic heart failure (CHF). Beta blockers can reduce body energy expenditure and improve efficiency of substrate utilization...
  23. ncbi request reprint Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, 9000, Murska Sobota, Slovenia
    Clin Rheumatol 26:1023-4. 2007
    ..boydii infection in a patient with microscopic polyangiitis. Favorable outcome related to the treatment with voriconazole adds to the growing body of evidence supporting the use of this particular agent in P. boydii infections...
  24. ncbi request reprint Heart failure clinic in a community hospital improves outcome in heart failure patients
    Mitja Lainscak
    General Hospital Murska Sobota, Department of Internal Medcine, Slovenia
    Swiss Med Wkly 136:274-80. 2006
    ..We aimed to compare the outcome, pharmacological therapy, and quality of life in unselected heart failure patients from a community hospital area who were managed either in the heart failure clinic or who received the usual care...
  25. ncbi request reprint International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Eur J Heart Fail 9:292-9. 2007
    ..This may reflect a lack of adequate organisation of care or co-morbidity contra-indicating therapy...
  26. doi request reprint Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial
    Mitja Lainscak
    Division of Cardiology, University Clinic or Respiratory and Allergic Diseases Colnik, Colnik, Slovenia
    Respir Med 105:S44-9. 2011
    ..This study compared effects of bisoprolol and carvedilol in patients with both conditions...
  27. ncbi request reprint Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey
    Mitja Lainscak
    Department of Internal Medicine, General Hospital Murska Sobota, Murska Sobota, Slovenia
    Am J Cardiol 99:31D-37D. 2007
    ..In addition, a substantial proportion of those who recall the advice follow it incompletely. Younger age and prescription of appropriate pharmacologic treatment are associated with higher rates of recall and implementation...
  28. doi request reprint Anaemia is an independent predictor of death in patients hospitalized for acute heart failure
    Stephan von Haehling
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
    Clin Res Cardiol 99:107-13. 2010
    ..Acute heart failure is associated with a poor prognosis. It is important to identify patients at increased risk of adverse events. The presence of anaemia could help in this regard...
  29. doi request reprint Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary disease
    Barbara Benedik
    University Clinic or Respiratory and Allergic Diseases Colnik, Colnik, Slovenia
    Respir Med 105:S38-43. 2011
    ..We have conceived this analysis to study the associations between MNA questionnaire, body composition, and rehospitalisations in patients with COPD...
  30. doi request reprint Effectiveness of discharge-coordinator intervention in patients with chronic obstructive pulmonary disease: study protocol of a randomized controlled clinical trial
    Jerneja Farkas
    Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
    Respir Med 105:S26-30. 2011
    ..This study was conceived to test whether coordinated discharge and post-discharge care could reduce re-hospitalizations and use of resources in patients with COPD...
  31. doi request reprint Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease
    Robert Marcun
    Department of Pneumology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    Int J Cardiol 161:156-9. 2012
    ..We aimed to investigate associations between N-terminal pro B-type natriuretic peptide (NT-proBNP) and troponin T during hospitalisation with 6-month outcome...
  32. pmc Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
    Hans Dirk Düngen
    Department of Internal Medicine Cardiology, Charite Universitatsmedizin, Competence Network Heart Failure, Campus Virchow Klinkum, Berlin, Germany
    Eur J Heart Fail 13:670-80. 2011
    ..The aim of this study was therefore to compare the tolerability and clinical effects of two proven beta-blockers in elderly patients with heart failure...
  33. ncbi request reprint Cardiac cachexia: a systematic overview
    Stephan von Haehling
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
    Pharmacol Ther 121:227-52. 2009
    ..Other drug classes of interest comprise angiotensin-converting enzyme inhibitors, beta-blockers, anabolic steroids, beta-adrenergic agonists, anti-inflammatory substances, statins, thalidomide, proteasome inhibitors, and pentoxifylline...
  34. doi request reprint Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial
    Hans Dirk Düngen
    Department of Cardiology, Competence Network Heart Failure, Campus Virchow Klinkum, Charite Universitatsmedizin, Berlin, Germany
    Clin Res Cardiol 97:578-86. 2008
    ..Beta-blockers have further not been adequately tested in patients with diastolic CHF, which is particularly common in elderly patients. Finally, comparative data on the use of different beta-blockers in patients with CHF is scarce...
  35. ncbi request reprint The effects of 8 weeks of endurance running on hepcidin concentrations, inflammatory parameters, and iron status in female runners
    Irena Auersperger
    Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia
    Int J Sport Nutr Exerc Metab 22:55-63. 2012
    ..The main findings of the current study indicate that serum hepcidin and sTfR were affected after 8 weeks of endurance running in women. No positive relation was found with inflammation...
  36. doi request reprint Self-rated health and mortality in patients with chronic heart failure
    Jerneja Farkas
    Chair of Public Health, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
    Eur J Heart Fail 11:518-24. 2009
    ..In patients with chronic heart failure (CHF), there is limited information on self-rated health (SRH). We aimed to examine the distribution of SRH and whether SRH is associated with mortality in patients with stable CHF...
  37. doi request reprint Mechanism and novel therapeutic approaches to wasting in chronic disease
    Nicole Ebner
    Applied Cachexia Research, Department of Cardiology, Charite University, Medical School, Campus Virchow Klinikum, Berlin, Germany
    Maturitas 75:199-206. 2013
    ..We discuss therapeutic targets and such potential modulators as appetite stimulants, selective androgen receptor modulators, amino acids and naturally occurring peptide hormones...
  38. doi request reprint Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review
    Wolfram Doehner
    Center for Stroke Research Berlin, Charite, Berlin, Germany
    Wien Klin Wochenschr 121:293-6. 2009
    ..Retrospective and epidemiological data for their beneficial effect in chronic obstructive pulmonary disease begin to accumulate and new fields (e.g. cancer and stroke) could be pending in the future...
  39. doi request reprint Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease
    Jerneja Farkas
    University of Ljubljana, Ljubljana, Slovenia
    Wien Klin Wochenschr 121:297-302. 2009
    ....
  40. doi request reprint Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPD
    Uros Meglic
    The University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
    Wien Klin Wochenschr 123:384-7. 2011
    ..Our results set the stage for future research to determine specific benefit of transcutaneous electrical muscle stimulation, either alone or in combination with nutritional support and pharmacological therapy...
  41. doi request reprint Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey
    Petra Jancar
    University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia
    Wien Klin Wochenschr 121:318-23. 2009
    ..There is little information on the preventive use of low-molecular-weight heparin (LMWH) in hospitalized patients with pneumonia...
  42. doi request reprint Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease
    Irena Sarc
    University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia
    J Eval Clin Pract 17:737-43. 2011
    ..This retrospective study aimed to assess the implementation of COPD guidelines and potential association with long-term mortality in patients with COPD...
  43. doi request reprint Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study
    Wolfram Doehner
    Center for Stroke Research Berlin, Charite Universitatsmedizin Berlin, Germany
    Int J Cardiol 161:137-42. 2012
    ..We aimed to test the ancillary metabolic effect of irbesartan on insulin sensitivity in patients with CHF...
  44. doi request reprint Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure
    Tibor Szabo
    Applied Cachexia Research, Department of Cardiology, Campus Virchow Klinikum, Charite University Medical School, Berlin, Germany
    Int J Cardiol 147:47-51. 2011
    ..Their value and discriminatory power in comparison to dynamic range assessment of Si by minimal modelling are not well established...
  45. doi request reprint Overview of emerging pharmacotherapy in chronic heart failure
    Tibor Szabo
    Charite Medical School, Campus Virchow Klinikum, Applied Cachexia Research, Department of Cardiology, Augustenburger Platz 1, 13353 Berlin, Germany
    Expert Opin Pharmacother 10:2055-74. 2009
    ..This review will focus on recent developments and potential future candidates of pharmacological CHF therapy...
  46. ncbi request reprint Atrial natriuretic peptide and related peptides
    Yoshihiro J Akashi
    Division of Applied Cachexia Research, Center for Cardiovascular Research, Charite Campus Mitte, Berlin, Germany
    Clin Chem Lab Med 45:1259-67. 2007
    ..This article summarizes existing data on ANP and related peptides in cardiovascular and other disorders, and outlines the potential clinical usefulness of these markers...
  47. doi request reprint Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders
    Stephan von Haehling
    Department of Cardiology, Applied Cachexia Research, Charite Medical School, Berlin, Germany
    Heart Fail Clin 5:549-60. 2009
    ..In addition to these acute phase reactants, several adhesion molecules, and lipopolysaccharide-signaling pathways are discussed...
  48. pmc Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study
    Stephan von Haehling
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany Center for Cardiovascular Research CCR, Charite Medical School, Campus Mitte, Berlin, Germany
    Arch Med Sci 9:261-7. 2013
    ..Using the novel Nexfin Finapres technique, we sought to assess measures of cardiac performance in patients with cancer and compare these values with those from control subjects and patients with chronic HF...
  49. doi request reprint Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease
    Wolfram Doehner
    Center for Stroke Research Berlin, Charite Medical School, Berlin, Germany
    Respir Med 105:S12-9. 2011
    ..Impaired glucose metabolism ranges from insulin resistance to overt diabetes mellitus, which is a frequent finding and is associated with worse outcome...
  50. doi request reprint Treatment of pulmonary hypertension: bench to bedside
    Jochen Springer
    Applied Cachexia Research, Charite Universitaetsmedizin Berlin, Berlin, Germany
    Respir Med 105:S7-11. 2011
    ..On the other hand, there have been failures such as vasoactive intestinal peptide, statins, and escitalopram. Several new drugs and gene therapy are under investigation, thus significant advances are anticipated...
  51. ncbi request reprint Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment
    Mitja Lainscak
    Internal Medicine Department, General Hospital Murska Sobota, Dr Vrbnjaka 6, SI 9000 Murska Sobota, Slovenia
    Int J Cardiol 97:411-6. 2004
    ..Intensive multidisciplinary approach can improve management of the patients with heart failure...
  52. ncbi request reprint The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose
    Darja Herman
    Institute of Biochemistry, Faculty of Medicine, Ljubljana, Slovenia
    Eur J Clin Pharmacol 62:291-6. 2006
    ..As, in many patients, drug co-treatment cannot be avoided, we investigated the effect of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose...
  53. pmc Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?
    Stanislav Suskovic
    Stanislav Suskovic, Department for Clinical Audit, University Clinic for Respiratory and Allergic Diseases Golnik, SI 4204 Golnik, Slovenia
    World J Cardiol 2:305-7. 2010
    ..Routine spirometry and echocardiography in HF and COPD patients, respectively, is therefore warranted to improve current clinical practice...
  54. ncbi request reprint Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of bisoprolol, ramiprilat, propranolol and midazolam in rat dried blood spots
    Katja Cvan Trobec
    University Clinic of Respiratory and Allergic Diseases Golnk, Pharmacy Department, Golnik 36, 4204 Golnik, Slovenia Electronic address
    J Chromatogr B Analyt Technol Biomed Life Sci 958:29-35. 2014
    ..The recovery was lowest for ramiprilat and highest for propranolol. Samples were stable at all tested temperatures. The method has been used successfully in a real-time pharmacokinetic study in rats. ..
  55. doi request reprint Estimation of renal function in lung cancer patients
    Katja Trobec
    Pharmacy Department, University Clinic Golnik, Golnik 36, 4204 Golnik, Slovenia
    Lung Cancer 76:397-402. 2012
    ....
  56. ncbi request reprint Assessment of physical fitness in adults by field testing supported by the specific software for personal computer based use
    Zlatko Fras
    University Medical Centre, Department of Vascular Medicine, Ljubljana, Slovenia CINDI Slovenia, Ljubljana, Slovenia
    Comput Biol Med 37:1377-83. 2007
    ..The test was integrated to exercise related health promotion programme, and widely available information technologies will be used for data management...
  57. doi request reprint Doping awareness, views, and experience: a comparison between general practitioners and pharmacists
    Irena Auersperger
    Faculty of Sport, University of Ljubljana, Ljubljana, Slovenia
    Wien Klin Wochenschr 124:32-8. 2012
    ..Information about doping awareness among medical professionals is scarce. We evaluated the attitudes, level of knowledge and experience among general practitioners (GPs) and pharmacists (Ps) with regard to doping...
  58. doi request reprint Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology
    Mitja Lainscak
    Division of Cardiology, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik 36 SI 4204 Golnik, Slovenia
    Eur J Heart Fail 13:115-26. 2011
    ..It also defines avenues of research to optimize self-care strategies in a number of key areas to derive further benefits...
  59. doi request reprint Challenges of beta blocker therapy in chronic heart failure: the story continues
    Mitja Lainscak
    Eur J Cardiovasc Nurs 7:159-60. 2008
    ..Nurse specialist has a decisive role in implementation of evidence based management which can have effects beyond patient care...
  60. ncbi request reprint Recommendations on sub-speciality accreditation in cardiology: The Coordination Task Force on Sub-speciality Accreditation of the European Board for the Speciality of Cardiology
    Jose Lopez-Sendon
    Cardiology Department, Planta 1, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid, Spain
    Eur Heart J 28:2163-71. 2007
  61. ncbi request reprint Prognostic role of body mass index after acute myocardial infarction
    Mitja Lainscak
    Am J Cardiol 98:1556-7. 2006
  62. ncbi request reprint Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease
    Mitja Lainscak
    Intern Med 45:837. 2006
  63. ncbi request reprint Survival and body fat in hemodialysis patients: true association or effects of concomitant therapy?
    Anja Sandek
    Am J Clin Nutr 84:663-4; author reply 634. 2006
  64. ncbi request reprint Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!
    Mitja Lainscak
    Eur J Heart Fail 9:2-3. 2007
    ..We discuss this study in detail. Further studies are needed to substantiate this link and to generally explore the value of testosterone therapy in CHF patients...